Matrix metalloproteinases (MMPs) have been proposed to play a key role in mediating glioma invasion through the parenchyma, and peri-tumoral reactive astrocytes have been shown, immunohistochemically, to express MMP2 in post-mortem samples (Nagashima et al., 2002). Here, MMP2 is linked to central nervous system cancer.